Key points are not available for this paper at this time.
Prurigo nodularis (PN) and chronic pruritus of unknown origin (CPUO) are chronic pruritic diseases that dramatically impair quality of life, but therapeutic options are limited. Abrocitinib, a Janus kinase 1 inhibitor, represents a promising therapy for both conditions.
Building similarity graph...
Analyzing shared references across papers
Loading...
Shawn G. Kwatra
Zachary A. Bordeaux
Varsha Parthasarathy
JAMA Dermatology
Johns Hopkins University
Duke University
Johns Hopkins Medicine
Building similarity graph...
Analyzing shared references across papers
Loading...
Kwatra et al. (Wed,) studied this question.
www.synapsesocial.com/papers/68e65f84b6db6435875ed4fb — DOI: https://doi.org/10.1001/jamadermatol.2024.1464